查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1462912

造血干细胞移植市场，按移植类型、按应用、按适应症、按配销通路、最终用户、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Hematopoietic Stem Cell Transplantation Market, By Transplant Type, By Application, By Indication, By Distribution Channel, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年造血干细胞移植市场规模为28.2312亿美元，2024年至2032年复合CAGR为10.7%。

造血干细胞移植市场-市场动态

白血病和淋巴瘤病例增加推动市场需求

由于白血病和淋巴瘤发病率的增加，预计造血干细胞移植市场将成长更快。根据白血病和淋巴瘤协会 2019 年报告，在美国，白血病、淋巴瘤或骨髓瘤确诊人数为 176,200 例，淋巴白血病和骨髓瘤患者存活率为 1,399,180 例。由于发病率上升，造血干细胞移植（HSCT）市场预计将成长。

造血干细胞移植市场-关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 10.7% 左右的CAGR成长

根据移植类型细分，自体移植预计将在预测期内占据最大的市场份额

根据应用细分，骨髓干细胞移植领域预计将在预测期内占据重要的市场份额

按地区划分，北美是 2023 年的主要收入来源

造血干细胞移植市场-細項分析：

全球造血干细胞移植市场根据移植类型应用、适应症、最终用户、治疗领域和地区进行细分。

根据移植类型，造血干细胞移植市场分为自体、同种异体和其他。由于技术的进步、血液疾病盛行率的增加以及干细胞疗法应用的扩大，预计自体部分在预测期内将占据最大的市场份额。

根据应用，造血干细胞移植产业分为脐带干细胞移植、骨髓干细胞移植、週边干细胞移植等。骨髓干细胞移植领域预计将在预测期内占据重要的市场份额。骨髓干细胞移植的主要适应症包括影响骨髓的非恶性疾病和多种血液恶性肿瘤。这些疾病可能包括淋巴瘤、骨髓增生异常综合症、再生障碍性贫血、急性和慢性白血病以及影响红血球生成的特定遗传性疾病。

根据指示，市场分为白血病、淋巴增殖性疾病、非恶性疾病和其他疾病。

根据配销通路，该行业分为线下和线上。

根据最终用户，造血干细胞移植市场分为零售药局、医院药局和专科诊所。

造血干细胞移植市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。预计北美将在预测期内占据最大的市场份额。北美地区的市场主要受到白血病患者数量增加以及政府和私营部门研发支出增加等因素的推动。例如，加拿大癌症协会2022年5月发布的统计数据显示，预计2022年将有6,700名加拿大人被诊断为白血病。 此外，该协会还表示，将有2,700名女性被诊断为白血病，其中1,300人将去世，4,000名男性将去世将接受白血病诊断。

造血干细胞移植市场-竞争格局：

市场主要参与者包括辉瑞公司、Akari Therapeutics, Plc、大冢美国製药公司、默克公司、武田製药有限公司、Lonza、葛兰素史克公司、诺华公司、默克公司、赛诺菲、富士胶片Holdings Corporation、bluebird bio, Inc.、Pluristem Therapeutics Inc.、Regen Biopharma Inc.、Kiadis Pharma、Taiga Biotechnologies, Inc.、CellGenix GmbH、Escape Therapeutics, Inc.、Marker Therapeutics, Inc.和Talaris Therapeutics。

最近的发展：

2022年5月，Priothera获得美国食品药物管理局批准，开始使用mocravimod治疗接受同种异体造血干细胞移植（HSCT）的急性髓性白血病（AML）患者的2b/3期研究。

目录

第一章：造血干细胞移植市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按移植类型分類的造血干细胞移植市场片段
    • 依应用分类的造血干细胞移植市场片段
    • 依适应症分类的造血干细胞移植市场片段
    • 按配销通路分類的造血干细胞移植市场片段
    • 最终用户的造血干细胞移植市场片段
    • 按国家/地区分類的造血干细胞移植市场片段
    • 按地区分類的造血干细胞移植市场片段
  • 竞争洞察

第 3 章：造血干细胞移植主要市场趋势

  • 造血干细胞移植市场驱动因素
    • 市场驱动因素的影响分析
  • 造血干细胞移植市场限制
    • 市场限制影响分析
  • 造血干细胞移植市场机会
  • 造血干细胞移植市场未来趋势

第四章：造血干细胞移植产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：造血干细胞移植市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：造血干细胞移植市场模式

  • 2023 年造血干细胞移植市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：造血干细胞移植市场 - 依移植类型

  • 概述
    • 按移植类型分類的细分市场份额分析
    • 自体
    • 同种异体
    • 其他的

第 8 章：造血干细胞移植市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 脐带干细胞移植
    • 骨髓干细胞移植
    • 週边干细胞移植
    • 其他的

第 9 章：造血干细胞移植市场 - 依适应症分类

  • 概述
    • 按指标分類的细分市场占有率分析
    • 白血病
    • 淋巴增生性疾病
    • 非恶性疾病
    • 其他的

第 10 章：造血干细胞移植市场 - 按配销通路

  • 概述
    • 按配销通路分類的细分市场份额分析
    • 离线
    • 在线的

第 11 章：造血干细胞移植市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 零售药房
    • 医院药房
    • 专科诊所

第 12 章：造血干细胞移植市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美造血干细胞移植主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按移植类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按指标）
    • 北美市场规模和预测（按配销通路）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲造血干细胞移植主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按移植类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模与预测（按指标）
    • 欧洲市场规模和预测（按配销通路）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区造血干细胞移植主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按移植类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模与预测（依指标）
    • 亚太地区市场规模和预测（按配销通路）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲造血干细胞移植主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按移植类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模与预测（按指标）
    • 拉丁美洲市场规模和预测（按配销通路）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲造血干细胞移植主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按移植类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（依指标）
    • 中东和非洲市场规模及预测（按配销通路）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第13章：主要供应商分析-造血干细胞移植产业

  • 竞争仪表板
  • 公司简介
    • Pfizer Inc.
    • Akari Therapeutics, Plc
    • Otsuka America Pharmaceutical, Inc.
    • Merck KGaA
    • Takeda Pharmaceutical Company Limited
    • Lonza
    • GlaxoSmithKline plc
    • Novartis AG
    • Merck & Co., Inc.
    • Sanofi
    • FUJIFILM Holdings Corporation
    • bluebird bio, Inc.
    • Pluristem Therapeutics Inc.
    • Regen Biopharma Inc.
    • Kiadis Pharma
    • Taiga Biotechnologies, Inc.
    • CellGenix GmbH
    • Escape Therapeutics, Inc.
    • Talaris Therapeutics
    • Marker Therapeutics, Inc.

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究应用学
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2370

REPORT HIGHLIGHT

Hematopoietic Stem Cell Transplantation Market size was valued at USD 2,823.12 Million in 2023, expanding at a CAGR of 10.7% from 2024 to 2032.

Many cancer forms and other illnesses can be treated with hematopoietic stem cell transplantation (HSCT). Two different sources of stem cells are bone marrow and blood. Hematopoietic stem cells are the young, immature blood cells found in bone marrow. The proportion of these blood cells that mature in the bone marrow and enter the bloodstream is quite low. The cells that reach the bloodstream are known as peripheral blood stem cells. After chemotherapy or radiation therapy, healthy hematopoietic stem cells are transplanted to replace absent, sick, or damaged hematopoietic stem cells.

Hematopoietic Stem Cell Transplantation Market- Market Dynamics

Increasing cases of leukemia and lymphoma to propel market demand

The market for hematopoietic stem cell transplantation is predicted to rise more rapidly due to the increased incidence of leukemia and lymphoma. In the United States, leukemia, lymphoma, or myeloma diagnosed 176,200 times, and lymph leukemia and myeloma survived in 1,399,180 cases, according to the Leukemia and Lymphoma Society's 2019 report. The market for hematopoietic stem cell transplantation (HSCT) is expected to grow as a result of the increasing incidence rate.

Hematopoietic Stem Cell Transplantation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.7% over the forecast period (2024-2032)

Based on transplant type segmentation, the Autologous segment is expected to hold the largest market share over the forecast period

Based on application segmentation, the Bone Marrow Stem Cell Transplant segment is expected to hold a significant market share over the projected period

Based on region, North America was the leading revenue generator in 2023

Hematopoietic Stem Cell Transplantation Market- Segmentation Analysis:

The Global Hematopoietic Stem Cell Transplantation Market is segmented based on Transplant Type Application, Indication, End User, Therapeutic Area, and Region.

Based on the transplant type, the Hematopoietic Stem Cell Transplantation market is segmented into Autologous, Allogeneic and Others. The Autologous segment is expected to hold the largest market share over the forecast period due to advancements in technology, increased prevalence of hematological disorders, and expanding applications of stem cell therapies.

Based on the application, the Hematopoietic Stem Cell Transplantation industry is bifurcated into Cord Stem Cell Transplant, Bone Marrow Stem Cell Transplant, Peripheral Stem Cell Transplant and Others. The Bone Marrow Stem Cell Transplant segment is expected to hold a significant market share over the projected period. The main indications for bone marrow stem cell transplantation include non-malignant bone marrow-affecting diseases and a variety of hematological malignancies. These could include lymphomas, myelodysplastic syndromes, aplastic anemia, acute and chronic leukemias, and specific hereditary illnesses that impact the generation of red blood cells.

Based on the indication, the market is bifurcated into Leukemia, Lymphoproliferative Disorders, Non-Malignant Disorders and Others.

Based on the distribution channel, the industry is bifurcated into Offline and Online.

Based on the end user, the Hematopoietic Stem Cell Transplantation market is bifurcated into Retail Pharmacy, Hospital Pharmacy and Specialty Clinics.

Hematopoietic Stem Cell Transplantation Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold the largest market share over the forecast period. The market in the North American area is primarily driven by factors such as the rising number of leukemia patients and increased governmental and private sector expenditure in research and development. For instance, statistics released in May 2022 by the Canadian Cancer Society indicates that 6,700 Canadians are anticipated to receive a leukemia diagnosis year 2022. Additionally, it stated that 2,700 women will receive a leukemia diagnosis, 1,300 of them will pass away, and 4,000 males will receive a leukemia diagnosis.

Hematopoietic Stem Cell Transplantation Market- Competitive Landscape:

The key players in the market are Pfizer Inc., Akari Therapeutics, Plc, Otsuka America Pharmaceutical, Inc., Merck KGaA, Takeda Pharmaceutical Company Limited, Lonza, GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Sanofi, FUJIFILM Holdings Corporation, bluebird bio, Inc., Pluristem Therapeutics Inc., Regen Biopharma Inc., Kiadis Pharma, Taiga Biotechnologies, Inc., CellGenix GmbH, Escape Therapeutics, Inc., Marker Therapeutics, Inc. and Talaris Therapeutics.

Recent Developments:

In May 2022, Priothera was granted approval by the US Food and Drug Administration to begin a Phase 2b/3 research using mocravimod in patients with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem cell transplantation (HSCT).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer Inc.

Akari Therapeutics, Plc

Otsuka America Pharmaceutical, Inc.

Merck KGaA

Takeda Pharmaceutical Company Limited

Lonza

GlaxoSmithKline plc

Novartis AG

Merck & Co., Inc.

Sanofi

FUJIFILM Holdings Corporation

bluebird bio, Inc.

Pluristem Therapeutics Inc.

Regen Biopharma Inc.

Kiadis Pharma

Taiga Biotechnologies, Inc.

CellGenix GmbH

Escape Therapeutics, Inc.

Talaris Therapeutics

Marker Therapeutics, Inc.

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Autologous
  • Allogeneic
  • Others

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cord Stem Cell Transplant
  • Bone Marrow Stem Cell Transplant
  • Peripheral Stem Cell Transplant
  • Others

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Leukemia
  • Lymphoproliferative Disorders
  • Non-Malignant Disorders
  • Others

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Offline
  • Online

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Retail Pharmacy
  • Hospital Pharmacy
  • Specialty Clinics

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Hematopoietic Stem Cell Transplantation Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Hematopoietic Stem Cell Transplantation Market Snippet by Transplant Type
    • 2.1.2.Hematopoietic Stem Cell Transplantation Market Snippet by Application
    • 2.1.3.Hematopoietic Stem Cell Transplantation Market Snippet by Indication
    • 2.1.4.Hematopoietic Stem Cell Transplantation Market Snippet by Distribution Channel
    • 2.1.5.Hematopoietic Stem Cell Transplantation Market Snippet by End User
    • 2.1.6.Hematopoietic Stem Cell Transplantation Market Snippet by Country
    • 2.1.7.Hematopoietic Stem Cell Transplantation Market Snippet by Region
  • 2.2.Competitive Insights

3.Hematopoietic Stem Cell Transplantation Key Market Trends

  • 3.1.Hematopoietic Stem Cell Transplantation Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Hematopoietic Stem Cell Transplantation Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Hematopoietic Stem Cell Transplantation Market Opportunities
  • 3.4.Hematopoietic Stem Cell Transplantation Market Future Trends

4.Hematopoietic Stem Cell Transplantation Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Hematopoietic Stem Cell Transplantation Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Hematopoietic Stem Cell Transplantation Market Landscape

  • 6.1.Hematopoietic Stem Cell Transplantation Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Hematopoietic Stem Cell Transplantation Market - By Transplant Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Transplant Type, 2023 & 2032 (%)
    • 7.1.2.Autologous
    • 7.1.3.Allogeneic
    • 7.1.4.Others

8.Hematopoietic Stem Cell Transplantation Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Cord Stem Cell Transplant
    • 8.1.3.Bone Marrow Stem Cell Transplant
    • 8.1.4.Peripheral Stem Cell Transplant
    • 8.1.5.Others

9.Hematopoietic Stem Cell Transplantation Market - By Indication

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 9.1.2.Leukemia
    • 9.1.3.Lymphoproliferative Disorders
    • 9.1.4.Non-Malignant Disorders
    • 9.1.5.Others

10.Hematopoietic Stem Cell Transplantation Market - By Distribution Channel

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 10.1.2.Offline
    • 10.1.3.Online

11.Hematopoietic Stem Cell Transplantation Market - By End User

  • 11.1.Overview
    • 11.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2.Retail Pharmacy
    • 11.1.3.Hospital Pharmacy
    • 11.1.4.Specialty Clinics

12.Hematopoietic Stem Cell Transplantation Market- By Geography

  • 12.1.Introduction
    • 12.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2.North America
    • 12.2.1.Overview
    • 12.2.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in North America
    • 12.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4.North America Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
    • 12.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.6.North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 12.2.7.North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.2.8.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9.U.S.
      • 12.2.9.1.Overview
      • 12.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3.U.S. Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.5.U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.2.9.6.U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.2.9.7.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10.Canada
      • 12.2.10.1.Overview
      • 12.2.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3.Canada Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.5.Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.2.10.6.Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.2.10.7.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.Europe
    • 12.3.1.Overview
    • 12.3.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in Europe
    • 12.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4.Europe Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
    • 12.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.6.Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 12.3.7.Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.8.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9.Germany
      • 12.3.9.1.Overview
      • 12.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3.Germany Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.5.Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.9.6.Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.9.7.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10.Italy
      • 12.3.10.1.Overview
      • 12.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3.Italy Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.5.Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.10.6.Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.10.7.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11.United Kingdom
      • 12.3.11.1.Overview
      • 12.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3.United Kingdom Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.5.United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.11.6.United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.11.7.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12.France
      • 12.3.12.1.Overview
      • 12.3.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3.France Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.5.France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.12.6.France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.12.7.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13.Russia
      • 12.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2.Russia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.4.Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.13.5.Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.13.6.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14.Netherlands
      • 12.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2.Netherlands Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.4.Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.14.5.Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.14.6.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15.Sweden
      • 12.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2.Sweden Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.4.Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.15.5.Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.15.6.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16.Poland
      • 12.3.16.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2.Poland Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.4.Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.16.5.Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.16.6.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17.Rest of Europe
      • 12.3.17.1.Overview
      • 12.3.17.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3.Rest of the Europe Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.5.Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.17.6.Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.17.7.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.Asia Pacific (APAC)
    • 12.4.1.Overview
    • 12.4.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in Asia Pacific
    • 12.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4.Asia Pacific Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
    • 12.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.6.Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 12.4.7.Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.8.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9.India
      • 12.4.9.1.Overview
      • 12.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3.India Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.5.India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.9.6.India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.9.7.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10.China
      • 12.4.10.1.Overview
      • 12.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3.China Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.5.China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.10.6.China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.10.7.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11.Japan
      • 12.4.11.1.Overview
      • 12.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3.Japan Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.5.Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.11.6.Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.11.7.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12.South Korea
      • 12.4.12.1.Overview
      • 12.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3.South Korea Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.5.South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.12.6.South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.12.7.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13.Australia
      • 12.4.13.1.Overview
      • 12.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3.Australia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.5.Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.13.6.Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.13.7.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14.Thailand
      • 12.4.14.1.Overview
      • 12.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3.Thailand Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.5.Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.14.6.Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.14.7.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15.Indonesia
      • 12.4.15.1.Overview
      • 12.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3.Indonesia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.5.Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.15.6.Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.15.7.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16.Philippines
      • 12.4.16.1.Overview
      • 12.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3.Philippines Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.5.Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.16.6.Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.16.7.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17.Rest of APAC
      • 12.4.17.1.Overview
      • 12.4.17.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3.Rest of APAC Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.5.Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.17.6.Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.17.7.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.Latin America
    • 12.5.1.Overview
    • 12.5.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in Latin America
    • 12.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4.Latin America Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
    • 12.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.6.Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 12.5.7.Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.5.8.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9.Brazil
      • 12.5.9.1.Overview
      • 12.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3.Brazil Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.5.Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.5.9.6.Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.9.7.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10.Mexico
      • 12.5.10.1.Overview
      • 12.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3.Mexico Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.5.Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.5.10.6.Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.10.7.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11.Argentina
      • 12.5.11.1.Overview
      • 12.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3.Argentina Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.5.Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.5.11.6.Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.11.7.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12.Colombia
      • 12.5.12.1.Overview
      • 12.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3.Colombia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.5.Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.5.12.6.Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.12.7.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13.Rest of LATAM
      • 12.5.13.1.Overview
      • 12.5.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3.Rest of LATAM Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.5.Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.5.13.6.Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.13.7.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.Middle East and Africa
    • 12.6.1.Overview
    • 12.6.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in Middle East and Africa
    • 12.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4.Middle East and Africa Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
    • 12.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.6.Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 12.6.7.Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.8.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9.Saudi Arabia
      • 12.6.9.1.Overview
      • 12.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3.Saudi Arabia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.5.Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.9.6.Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.9.7.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10.United Arab Emirates
      • 12.6.10.1.Overview
      • 12.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3.United Arab Emirates Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.5.United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.10.6.United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.10.7.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11.Israel
      • 12.6.11.1.Overview
      • 12.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3.Israel Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.5.Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.11.6.Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.11.7.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12.Turkey
      • 12.6.12.1.Overview
      • 12.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3.Turkey Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.5.Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.12.6.Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.12.7.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13.Algeria
      • 12.6.13.1.Overview
      • 12.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3.Algeria Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.5.Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.13.6.Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.13.7.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14.Egypt
      • 12.6.14.1.Overview
      • 12.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3.Egypt Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.5.Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.14.6.Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.14.7.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15.Rest of MEA
      • 12.6.15.1.Overview
      • 12.6.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3.Rest of MEA Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.5.Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.15.6.Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.15.7.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13.Key Vendor Analysis- Hematopoietic Stem Cell Transplantation Industry

  • 13.1.Competitive Dashboard
  • 13.2.Company Profiles
    • 13.2.1.Pfizer Inc.
    • 13.2.2.Akari Therapeutics, Plc
    • 13.2.3.Otsuka America Pharmaceutical, Inc.
    • 13.2.4.Merck KGaA
    • 13.2.5.Takeda Pharmaceutical Company Limited
    • 13.2.6.Lonza
    • 13.2.7.GlaxoSmithKline plc
    • 13.2.8.Novartis AG
    • 13.2.9.Merck & Co., Inc.
    • 13.2.10.Sanofi
    • 13.2.11.FUJIFILM Holdings Corporation
    • 13.2.12.bluebird bio, Inc.
    • 13.2.13.Pluristem Therapeutics Inc.
    • 13.2.14.Regen Biopharma Inc.
    • 13.2.15.Kiadis Pharma
    • 13.2.16.Taiga Biotechnologies, Inc.
    • 13.2.17.CellGenix GmbH
    • 13.2.18.Escape Therapeutics, Inc.
    • 13.2.19.Talaris Therapeutics
    • 13.2.20.Marker Therapeutics, Inc.

14.360 Degree Analyst View

15.Appendix

  • 15.1.Research Applicationology
  • 15.2.References
  • 15.3.Abbreviations
  • 15.4.Disclaimer
  • 15.5.Contact Usq

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Hematopoietic Stem Cell Transplantation Market: Transplant Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Transplant Type
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by Transplant Type 2019-2032 (USD Million)
  • TABLE Hematopoietic Stem Cell Transplantation Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by Application 2019-2032 (USD Million)
  • TABLE Hematopoietic Stem Cell Transplantation Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by Indication 2019-2032 (USD Million)
  • TABLE Hematopoietic Stem Cell Transplantation Market: Distribution Channel Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by Distribution Channel 2019-2032 (USD Million)
  • TABLE Hematopoietic Stem Cell Transplantation Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by End User 2019-2032 (USD Million)
  • TABLE Hematopoietic Stem Cell Transplantation Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by Region 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by Transplant Type, 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by Transplant Type, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by Transplant Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by Transplant Type, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by Transplant Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)